Fort Sheridan Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.97M Buy
8,433
+1,269
+18% +$452K 0.36% 51
2025
Q4
$2.34M Buy
7,164
+269
+4% +$85.3K 0.3% 57
2025
Q3
$1.95M Buy
6,895
+133
+2% +$38.6K 0.25% 72
2025
Q2
$1.89M Sell
6,762
-185
-3% -$52.4K 0.27% 67
2025
Q1
$2.16M Buy
6,947
+169
+2% +$49.9K 0.33% 59
2024
Q4
$1.77M Buy
6,778
+916
+16% +$272K 0.26% 68
2024
Q3
$1.89M Buy
5,862
+82
+1% +$26.8K 0.29% 67
2024
Q2
$1.81M Buy
5,780
+1,481
+34% +$435K 0.29% 64
2024
Q1
$1.22M Buy
4,299
+579
+16% +$169K 0.23% 76
2023
Q4
$1.07M Buy
3,720
+50
+1% +$13.6K 0.21% 76
2023
Q3
$986K Buy
3,670
+850
+30% +$212K 0.22% 78
2023
Q2
$626K Buy
2,820
+873
+45% +$203K 0.14% 102
2023
Q1
$471K Buy
1,947
+21
+1% +$5.16K 0.12% 116
2022
Q4
$506K Hold
1,926
0.16% 104
2022
Q3
$434K Buy
1,926
+41
+2% +$9.94K 0.15% 108
2022
Q2
$459K Buy
1,885
+670
+55% +$164K 0.15% 106
2022
Q1
$294K Sell
1,215
-16
-1% -$3.68K 0.09% 146
2021
Q4
$277K Sell
1,231
-642
-34% -$135K 0.08% 159
2021
Q3
$398K Sell
1,873
-19
-1% -$4.37K 0.13% 116
2021
Q2
$461K Buy
1,892
+11
+0.6% +$2.71K 0.15% 101
2021
Q1
$468K Hold
1,881
0.19% 81
2020
Q4
$432K Hold
1,881
0.21% 67
2020
Q3
$478K Buy
1,881
+6
+0.3% +$1.49K 0.28% 53
2020
Q2
$442K Sell
1,875
-22
-1% -$5.02K 0.27% 53
2020
Q1
$385K Hold
1,897
0.28% 51
2019
Q4
$457K Buy
1,897
+303
+19% +$66.8K 0.25% 61
2019
Q3
$308K Buy
+1,594
New +$306K 0.17% 69

Other funds holding AMGN

Fort Sheridan Advisors's AMGN Position: Q1 2026 in Review

Fort Sheridan Advisors increased its Amgen (AMGN) stake by 18% in Q1 2026, buying an estimated $452K and bringing the position to 8,433 shares worth $2.97M. The position accounts for 0.36% of the portfolio, ranked #51.

Fort Sheridan Advisors first reported a position in AMGN in Q3 2019 and has held it in 27 quarters since. 3,130 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Fort Sheridan Advisors held 8,433 shares of Amgen worth $2.97M as of Q1 2026.
  • Fort Sheridan Advisors bought 1,269 Amgen shares in Q1 2026, an estimated $452K.
  • Amgen made up 0.36% of Fort Sheridan Advisors's portfolio in Q1 2026, its #51 holding.
  • Fort Sheridan Advisors first reported a position in Amgen in Q3 2019 and has held it in 27 quarters since.
  • 3,130 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Fort Sheridan Advisors's 13F filing for Q1 2026, filed 6 May 2026.